Infosys has taken a major step forward in the UK tech landscape with the launch of its expanded Living Labs in London and a newly established AI Lab in partnership with the University of Cambridge. This collaboration is expected to accelerate enterprise innovation through a dynamic blend of advanced AI, digital transformation, and academic expertise. […]
Olatec Therapeutics, Inc. (Olatec), a leader in the field of selective NLRP3 inhibitors, has embarked on a journey to tackle Parkinson’s disease, a neurodegenerative disorder that has long eluded effective treatment. With a generous grant from Cure Parkinson’s, Olatec is set to initiate a Phase 2 clinical trial for oral dapansutrile, aiming to explore its […]
NeoGenomics, a US-based cancer diagnostics and pharma services company, has wrapped up its previously announced $390 million takeover of Inivata, a liquid biopsy platform company based in Cambridge, England. The deal was announced in May 2021 by NeoGenomics as it exercised a purchase option to acquire the remaining equity interest in Inivata. A year prior […]